Skip to main content

Table 4 PSS values (mean ± SD) at pre-treatment (day 0), day 14 and day 28 for each group

From: The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis

 

Time

Firocoxib

PCSO-524

Combination

P-value*

PSS

Day 0 (point)

1.89 ± 2.02 a

2.67 ± 2.58 a

2.04 ± 2.40 a

0.4834

 

Day 14 (point)

1.78 ± 1.82 a

2.40 ± 2.36 ab

1.63 ± 1.73 a

 
 

Day 28 (point)

1.88 ± 1.97 a

1.56 ± 1.64 b

1.27 ± 1.98 a

 
  1. SD standard deviation
  2. a, bp-value < 0.05 from Tukey’s Studentized Range within each treatment
  3. *p-value from repeated measurement analysis for 3 treatments
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us